B

Boston Scientific Corp

BSX•NYSE•HEALTHCARE
$46.01+0.00 (+0.00%)
Market closed•Prev close $46.01

Price action

Daily adjusted bars

2signals overlaid
Prior signal2

Snapshot

Key stats

AV May 30
Market cap
$75.00B
P/E ratio
21.11
Forward P/E
14.93
Beta
0.62
52W range
$48.12 - $109.50
Dividend yield
--
Volume
2.75M
Sector
HEALTHCARE

Analyst

Consensus price target

Live

Current

$46.01

Target

$83.47

+37.46 (+81.4%) upside12mo horizon

AlphaYou verdict

Insider Cluster

LONGLive
22/ 100
WeakScore 22 / 100Issued May 29, 2026

Smart-money signal on BSX this 14d.

  • Smart money6.0/40
  • Fundamentals6.5/35
  • Technicals6.0/15
  • Macro3.3/10

Receipts

Recent signals for this ticker

LiveAll signals
  • LONGMay 29
    Insider Cluster

    Smart-money signal on BSX this 14d.

    Public Recommendation·Checkpoints pending
  • LONGMay 22
    Insider Cluster

    3 insiders bought $554K of BSX this 14d.

    Public Recommendation·Checkpoints pending

Smart money

Insider, fund, and political flow

Live18 receipts

  • filing nport p fund flow

    JANUS INVESTMENT FUND [Janus Henderson Global Select Fund] opened position ($27.3M)

    +4.0

  • filing nport p fund flow

    JANUS INVESTMENT FUND [Janus Henderson Balanced Fund] opened position ($73.6M)

    +4.0

  • filing 13f fund flow

    Renaissance Technologies LLC holds $227.2M (13F 2025-12-31)

    +5.0

  • filing 13f fund flow

    Two Sigma Investments LP holds $590.6M (13F 2026-03-31)

    +4.0

  • filing 13f fund flow

    Citadel Advisors LLC holds $455.4M (13F 2025-12-31)

    +4.0

  • filing nport p fund flow

    American Funds Insurance Series holds $233.8M (NPORT-P 2025-12-31)

    +4.0

Top trader activity

Pending

Copy-trading signal layer from real US-equity operators. Wires in once the CopyTrading feed is mapped to US-stock tickers.

BTC Astro risk regime

Pending

Cross-asset risk timing overlay. Used as context only, never a primary stock source.

Reputation

Sources and actors behind this ticker

LiveDirectory

Source families

Actors and filers

Checkpoint ledger

Public recommendation outcomes

Pending

No public recommendation checkpoints have landed for this ticker yet.

D7 appears first, then D15 and D30 as the call matures.

Each row is a public recommendation. Alpha columns compare the frozen issued price with SPY, QQQ, and sector ETF checkpoints when available.

Raw source coverage

Primary-source receipt chain

LiveMethod
100.0%
Linked
6
Events
2
Signals
2
Recs
Source coverage6/6
SEC EDGAR Form 43/3 linked
SEC EDGAR NPORT-P2/2 linked
SEC EDGAR 13F1/1 linked
Recent source events

  • SEC EDGAR NPORT-P

    FILING NPORT P FUND FLOW · May 29· source

    raw linked

  • SEC EDGAR NPORT-P

    FILING NPORT P FUND FLOW · May 29· source

    raw linked

  • SEC EDGAR Form 4

    INSIDER BUY · May 21· source

    raw linked

  • SEC EDGAR Form 4

    INSIDER BUY · May 21· source

    raw linked

  • SEC EDGAR Form 4

    INSIDER BUY · May 21· source

    raw linked

  • SEC EDGAR 13F

    FILING 13F FUND FLOW · May 15· source

    raw linked

Fundamentals

Valuation, quality, growth

Live

Valuation

  • P/E21.11
  • Forward P/E14.93
  • P/S3.64
  • P/B2.90

Quality

  • Profit margin17.3%
  • Operating margin20.6%
  • ROE14.7%
  • ROA6.1%

Growth

  • Revenue YoY--
  • Earnings YoY--
  • Beta0.62
  • Dividend yield--

Technicals

Trend, momentum, levels

Live

Trailing returns

  • 5d+0.44%
  • 20d-0.13%
  • 60d+0.13%

Trend vs SMAs

  • vs SMA50+0.57%
  • vs SMA200-0.56%

52w range position

$48.120%$109.50

Computed from AV daily adjusted bars. No options-flow, IV, or order-book signals on this page yet.

Macro

Sector + regime context

Live

  • macro regime shift

    VIX 15.7 (low volatility) as of 2026-05-28

    +15.7

  • macro regime shift

    10y-2y spread 46bps (flattish) as of 2026-05-28

    +0.5

  • macro regime shift

    Industrial Production 102.5 (mild expansion) as of 2026-04-01

    +102.5

  • macro regime shift

    Initial claims 215,000 vs 26w mean (ratio 1.01, neutral)

    +1.0

  • macro regime shift

    CPI YoY 3.95% (hot vs Fed target)

    +4.0

Earnings

EPS beat / miss history

Live
$0.83$0.76$0.69$0.62$0.55Q2 '24Q4 '24Q2 '25Q4 '25Q1 '26
BeatMissMatchEstimate

Debate

Key issues

Live

  • Bullish view

    • JANUS INVESTMENT FUND [Janus Henderson Global Select Fund] opened position ($27.3M)
    • JANUS INVESTMENT FUND [Janus Henderson Balanced Fund] opened position ($73.6M)
    • Renaissance Technologies LLC holds $227.2M (13F 2025-12-31)
    • Two Sigma Investments LP holds $590.6M (13F 2026-03-31)

    Bearish view

    • Pending dilution: 1 S-3/S-8 shelf in trailing 90d
    • Pending dilution: 1 S-3/S-8 shelf in trailing 90d

Arguments are pulled from contributing receipts (Form 4 / 13F / fundamentals / macro) for this ticker. Each side carries the count of receipts behind it, not an analyst headline count.

Track record

Recommendation receipts

LiveFull page

vs SPY

S&P 500

1 rec · 1L · 0S

Median alpha

-16.92%

Mean alpha

-16.92%

Hit rate

0.0%

Mean return

-15.47%

vs QQQ

Nasdaq-100

1 rec · 1L · 0S

Median alpha

-18.36%

Mean alpha

-18.36%

Hit rate

0.0%

Mean return

-15.47%

D7 recommendation-counted alpha. Each receipt aggregates same-day same-direction signals into one row to avoid double-counting.